596 related articles for article (PubMed ID: 8700536)
1. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
Morelli S; Alama A; Quattrone A; Gong L; Copreni E; Canti G; Nicolin A
Anticancer Drug Des; 1996 Jan; 11(1):1-14. PubMed ID: 8639245
[TBL] [Abstract][Full Text] [Related]
3. BCL-2 regulation targeting the AU-rich domain.
Bevilacqua A; Ceriani MC; Schiavone N; Nicolin A
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1273-9. PubMed ID: 11097057
[TBL] [Abstract][Full Text] [Related]
4. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
5. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
[TBL] [Abstract][Full Text] [Related]
7. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
8. Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene.
Hua C; Zorn S; Jensen JP; Coupland RW; Ko HS; Wright JJ; Bakhshi A
Oncogene Res; 1988 Feb; 2(3):263-75. PubMed ID: 3285301
[TBL] [Abstract][Full Text] [Related]
9. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
Pezzella F; Mason DY
Nouv Rev Fr Hematol (1978); 1990; 32(6):397-9. PubMed ID: 2101872
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
[TBL] [Abstract][Full Text] [Related]
11. Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
Welzel N; Le T; Marculescu R; Mitterbauer G; Chott A; Pott C; Kneba M; Du MQ; Kusec R; Drach J; Raderer M; Mannhalter C; Lechner K; Nadel B; Jaeger U
Cancer Res; 2001 Feb; 61(4):1629-36. PubMed ID: 11245476
[TBL] [Abstract][Full Text] [Related]
12. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
Masir N; Campbell LJ; Jones M; Mason DY
Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.
Heckman CA; Wheeler MA; Boxer LM
Oncogene; 2003 Sep; 22(39):7891-9. PubMed ID: 12970736
[TBL] [Abstract][Full Text] [Related]
14. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
Larsen CJ; Mecucci C; Leroux D
Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
16. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma.
Abdel-Reheim FA; Edwards E; Arber DA
Arch Pathol Lab Med; 1996 Apr; 120(4):357-63. PubMed ID: 8619747
[TBL] [Abstract][Full Text] [Related]
17. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
[TBL] [Abstract][Full Text] [Related]
18. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
Stoos-Veić T; Livun A; Ajduković R; Pejsa V; Jaksić O; Kusec R
Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
[TBL] [Abstract][Full Text] [Related]
19. The antisense bcl-2-IgH transcript is an optimal target for synthetic oligonucleotides.
Morelli S; Delia D; Capaccioli S; Quattrone A; Schiavone N; Bevilacqua A; Tomasini S; Nicolin A
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8150-5. PubMed ID: 9223330
[TBL] [Abstract][Full Text] [Related]
20. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Schmitt C; Balogh B; Grundt A; Buchholtz C; Leo A; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]